Deadline: 23-Jul-25
The Pfizer is requesting grant proposals to support Quality Improvement (QI) projects that integrate Shared Decision Making tools and care algorithms into hemophilia patient care.
Shared Decision Making (SDM) plays a vital role in the interaction between individuals living with hemophilia (PlwH), their caregivers, and the multidisciplinary teams at hemophilia treatment centers.
Areas of Interest
- It is their intent to support projects focusing on:
- Implementing shared decision making (SDM) tools and/or management of care algorithms into hemophilia patient care. Multi-disciplinary collaborations are encouraged when appropriate, but all partners must have a relevant role.
- Identifying significant barriers that contribute to geographic, gender and racial healthcare disparities disproportionately impacting the Hemophilia community. The goal is to enhance early detection and determine targeted interventions that address these challenges with focus on SDM.
- Exploring empowering strategies that enable patients to actively participate in their care, as well as in making informed decisions regarding disease management options.
Funding Information
- Individual projects requesting up to $30,000 will be considered. Pfizer anticipates awarding 2 grants.
- Project Length can be up to 18 months.
Target Audience
- People living with hemophilia, caregivers and members of multidisciplinary teams that care for Hemophilia patients including but not limited to Hematologists, Pharmacists, Specialty Nurses, Orthopedist, Genetic Counsellors, and other Physicians.
Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
For more information, visit Pfizer.